Therapeutic Efficacy of Kangfuxin Liquid Combined with PPIs in Gastric Ulcer

Table 1

Characteristics of eligible studies.

Author and published year (references)	Cases T/C	Diagnostic standard	Age (years),; range, mean	Sex (male/female)
Li, 2012 [20]	65/65	DTDUD (2008)	T: 24–69, 43.2	T: 45/20
			C: 22–70, 41.3	C: 47/18
Xiang, 2013 [21]	59/61	GPCRTPU	T: 39.4	NR
			C: 40.7
Zhang, 2009 [22]	25/24	DDD (2006)	T: 27–52, 38	T: 16/9
			C: 29–58, 39	C: 13/11
Zhang, 2013 [23]	34/32	Gastroscopy	T: 24–68, 34	T: 20/14
			C: 20–65, 32	C: 19/13
Huang, 2014 [24]	88/42	Gastroscopy	T: 18–60, NR	NR
			C: 18–60, NR
Huang, 2016 [25]	36/36	DTDUD (2013)	T: 29–76, 35.6	T: 21/15
			C: 28–74, 35.5	C: 20/16
McGrady, 2016 [26]	43/43	DTDUD (2013)	T: 20–65, 35.6	T: 28/15
			C: 20–66, 36.1	C: 25/18
Xuan, 2008 [27]	38/40	Gastroscopy	T: 20–65, NR	NR
			C: 20–65, NR
Zhu, 2016 [28]	80/80	Gastroscopy	T: 23–67, 38.9	T: 52/28
			C: 19–65, 39.4	C: 49/31
Zhou, 2016 [29]	62/62	Gastroscopy	T: 47.2	T: 37//25
			C: 46.4	C: 36/26
He, 2014 [30]	35/32	Gastroscopy	T: 18–72, 43	T: 23/12
			C: 20–75, 45	C: 22/10
Chen, 2012 [31]	26/27	Gastroscopy	24–78, 61.5	28/25
Ou, 2014 [32]	25/25	Gastroscopy	25–60, 45	26/24
Yu, 2016 [33]	60/60	DTDUD (2013)	18–70, NR	T: 40/20
				C: 42/18
Chen, 2017 [15]	25/24	DTDUD (2016)	T: 27–67, 44.5	T: 14/11
			C: 26–68, 45.2	C: 15/9
Fan, 2015 [34]	58/51	Gastroscopy	T: 43.8	T: 29/29
			C: 42.6	C: 30/21
Liang, 2011 [35]	23/20	Gastroscopy	T: 31–77, 49.1	T: 15/8
			C: 27–72, 46.6	C: 11/9
Peng, 2010 [36]	40/40	Gastroscopy	T: 19–43, 33.5	T: 26/14
			C: 19–42, 32.4	C: 28/12
Tian, 2015 [37]	60/60	PCDTDD (2005)	T: 17–67, 34.5	T: 42/18
			C: 19–71, 33.5	C: 40/20
Ye, 2007 [38]	33/32	Gastroscopy	T: 20–63, 38.5	NR
			C: 20–65, 39.8
Zhang, 2015 [39]	70/70	NR	T: 23–72, 45.2	T: 42/28
			C: 25–70, 43.3	C: 43/27
Zhang, 2015 [40]	37/37	Gastroscopy	T: 29–72, 34.7	T: 26/11
			C: 28–75, 35.8	C: 24/13

T, trial group; C, control group; NR, no report.